Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats

被引:31
作者
Zelena, D
Filaretova, L
Mergl, Z
Barna, I
Tóth, ZE
Makara, GB
机构
[1] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary
[2] Semmelweis Univ, Sch Med, Neuromorphol Lab, Budapest, Hungary
[3] IP Pavlov Physiol Inst, Lab Expt Endocrinol, St Petersburg 199034, Russia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2006年 / 290卷 / 02期
关键词
chronic stress; Brattleboro rats; corticosterone; proopiomelanocortin; corticotropin-releasing hormone; diabetes mellitus; hypothalamo-pituitary-adrenocortical axis;
D O I
10.1152/ajpendo.00118.2005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus ( DM), as chronic stress activates the hypothalamo-pituitary-adrenocortical axis. We examined whether arginine vasopressin ( AVP) and the hypothalamic paraventricular nucleus ( PVN) participate in DM-induced chronic stress symptoms. AVP-deficient Brattleboro or PVN-lesioned Wistar rats were used with heterozygous or sham-operated controls. The rats were studied 2 wk after a single injection of streptozotocin. The appearance of DM ( enhanced water consumption and blood glucose elevation) and the chronic stress-like somatic changes ( body weight decrease, thymus involution, adrenal gland hypertrophy) were not influenced by the lack of AVP. By contrast, PVN lesion significantly attenuated DM-induced thymus involution and adrenal gland hypertrophy as well as the increase in water consumption. The corticotropin-releasing hormone mRNA in PVN was diminished by DM and elevated by the lack of AVP without interaction. DM elevated the proopiomelanocortin ( POMC) mRNA in the anterior lobe of the pituitary. The lack of AVP had no effect, whereas lesioning the PVN significantly diminished the elevation. The elevated basal corticosterone plasma levels detectable in DM were influenced neither by the lack of AVP nor by lesioning the PVN. Thus the lack of AVP had no influence on DM-induced chronic stress symptoms, but lesioning the PVN attenuated part of them. However, the lack of elevation in POMC mRNA after PVN lesion, together with the maintained corticosterone elevation, suggests that direct adrenal gland activation occurs in untreated DM.
引用
收藏
页码:E243 / E250
页数:8
相关论文
共 47 条
  • [1] REGULATION OF PITUITARY ACTH-SECRETION DURING CHRONIC STRESS
    AGUILERA, G
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1994, 15 (04) : 321 - 350
  • [2] Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
  • [3] VASOPRESSINERGIC CONTROL OF PITUITARY ADRENOCORTICOTROPIN SECRETION COMES OF AGE
    ANTONI, FA
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) : 76 - 122
  • [4] Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala
    Bakshi, VP
    Smith-Roe, S
    Newman, SM
    Grigoriadis, DE
    Kalin, NH
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (07) : 2926 - 2935
  • [5] Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats
    Bardoux, P
    Martin, H
    Ahloulay, M
    Schmitt, F
    Bouby, N
    Trinh-Trang-Tan, MM
    Bankir, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10397 - 10402
  • [6] Gender-specific effect of maternal deprivation on anxiety and corticotropin-releasing hormone mRNA expression in rats
    Barna, I
    Bálint, E
    Baranyi, J
    Bakos, N
    Makara, GB
    Haller, J
    [J]. BRAIN RESEARCH BULLETIN, 2003, 62 (02) : 85 - 91
  • [7] Björntorp P, 2002, NOVART FDN SYMP, V242, P46
  • [8] VASOPRESSIN IN RATS WITH GENETIC AND STREPTOZOCIN-INDUCED DIABETES
    BROOKS, DP
    NUTTING, DF
    CROFTON, JT
    SHARE, L
    [J]. DIABETES, 1989, 38 (01) : 54 - 57
  • [9] Neuroendocrine pharmacology of stress
    Carrasco, GA
    de Kar, LDV
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 463 (1-3) : 235 - 272
  • [10] Occult Cushing's syndrome in type-2 diabetes
    Catargi, B
    Rigalleau, V
    Poussin, A
    Ronci-Chaix, N
    Bex, V
    Vergnot, V
    Gin, H
    Roger, P
    Tabarin, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) : 5808 - 5813